Marwane Berrada-Sounni

Advanced Nanotherapies, Inc. engages in the provision of medical device company that is developing a nanoparticle technology-based platform for drug delivery. It develops novel sirolimus-based medical devices to treat atherosclerosis and blockage for coronary artery disease and peripheral artery disease. The company was founded by Marwane Berrada-Sounni and Mehdi Shishehbor and is headquartered in Cleveland, OH.

Advanced Nanotherapies, Inc. engages in the provision of medical device company that is developing a nanoparticle technology-based platform for drug delivery. It develops novel sirolimus-based medical devices to treat atherosclerosis and blockage for coronary artery disease and peripheral artery disease. The company was founded by Marwane Berrada-Sounni and Mehdi Shishehbor and is headquartered in Cleveland, OH.

Advanced Nanotherapies, Inc. engages in the provision of medical device company that is developing a nanoparticle technology-based platform for drug delivery. It develops novel sirolimus-based medical devices to treat atherosclerosis and blockage for coronary artery disease and peripheral artery disease. The company was founded by Marwane Berrada-Sounni and Mehdi Shishehbor and is headquartered in Cleveland, OH.